10/12/2024 | 22:35 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/12/2024 | 22:30 | GLOBE | Cellectis announces the drawdown of the third tranche of €5.. |
05/11/2024 | 22:30 | GLOBE | Cellectis Presents Multiple Strategies to Enhance CAR T-cell.. |
04/11/2024 | 22:30 | GLOBE | Cellectis Provides Business Updates and Financial Results.. |
30/10/2024 | 21:35 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
30/10/2024 | 21:30 | GLOBE | Cellectis to Report Third Quarter 2024 Financial Results on.. |
22/10/2024 | 08:00 | GLOBE | Cellectis to Present Data on TALE-Base Editors and Non-Viral.. |
11/9/2024 | 22:30 | EDGAR2 | Form 6-K/A - Report of foreign issuer [Rules 13a-16 and.. |
03/9/2024 | 22:30 | GLOBE | Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells.. |
26/8/2024 | 22:31 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
26/8/2024 | 22:30 | GLOBE | Cellectis Publishes a Molecular Therapy Article on a SMART.. |
07/8/2024 | 12:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
07/8/2024 | 08:00 | GLOBE | Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical.. |
06/8/2024 | 22:30 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06/8/2024 | 22:30 | GLOBE | Cellectis Provides Financial Results for the Second Quarter.. |
01/8/2024 | 22:30 | GLOBE | FDA Grants Orphan Drug Designation to Cellectis’ CLLS52.. |
25/7/2024 | 22:30 | GLOBE | FDA Grants Orphan Drug and Rare Pediatric Disease.. |
28/6/2024 | 22:30 | GLOBE | Cellectis Reports Results from Shareholders Meeting Held on.. |
20/6/2024 | 22:30 | GLOBE | Cellectis Publishes a Scientific Article Unveiling Three Key.. |
12/6/2024 | 22:35 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/6/2024 | 22:30 | GLOBE | Cellectis Unveils a Non-Viral Gene Therapy Approach for.. |
04/6/2024 | 22:41 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
04/6/2024 | 22:30 | GLOBE | Cellectis Receives Orphan Drug Designation for UCART22, its.. |
29/5/2024 | 22:35 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
29/5/2024 | 22:30 | GLOBE | Cellectis’ Annual Shareholders General Meeting to be Held on.. |
28/5/2024 | 22:30 | GLOBE | Cellectis Reports Financial Results for First Quarter 2024 |
28/5/2024 | 12:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
27/5/2024 | 22:30 | GLOBE | Cellectis to Report First Quarter 2024 Financial Results on.. |
24/5/2024 | 22:06 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06/5/2024 | 12:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06/5/2024 | 08:00 | GLOBE | Cellectis Announces Completion of the Additional Equity.. |
02/5/2024 | 22:30 | GLOBE | Cellectis Appoints Arthur Stril as Interim Chief Financial.. |
29/4/2024 | 22:46 | GLOBE | Cellectis Reports Financial Results for the Fourth Quarter.. |
22/4/2024 | 22:30 | GLOBE | Cellectis Presents Novel TALEN® Editing Processes Enabling.. |
10/4/2024 | 22:30 | GLOBE | Cellectis Publishes a Novel Intronic Gene Editing Approach.. |
08/4/2024 | 22:30 | GLOBE | Cellectis Announces Two Poster Presentations on Novel TALEN®.. |